Departamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, INER, Ciudad de Mexico, Mexico.
Servicio de Urgencias Médicas, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, INER, Ciudad de Mexico, Mexico.
Virol J. 2023 Feb 1;20(1):19. doi: 10.1186/s12985-023-01979-3.
Several factors are associated with the severity of the respiratory disease caused by the influenza virus. Although viral factors are one of the most studied, in recent years the role of the microbiota and co-infections in severe and fatal outcomes has been recognized. However, most of the work has focused on the microbiota of the upper respiratory tract (URT), hindering potential insights from the lower respiratory tract (LRT) that may help to understand the role of the microbiota in Influenza disease. In this work, we characterized the microbiota of the LRT of patients with Influenza A using 16S rRNA sequencing. We tested if patients with different outcomes (deceased/recovered) and use of antibiotics differ in their microbial community composition. We found important differences in the diversity and composition of the microbiota between deceased and recovered patients. In particular, we detected a high abundance of opportunistic pathogens such as Granulicatella, in patients either deceased or with antibiotic treatment. Also, we found antibiotic treatment correlated with lower diversity of microbial communities and with lower probability of survival in Influenza A patients. Altogether, the loss of microbial diversity could generate a disequilibrium in the community, potentially compromising the immune response increasing viral infectivity, promoting the growth of potentially pathogenic bacteria that, together with altered biochemical parameters, can be leading to severe forms of the disease. Overall, the present study gives one of the first characterizations of the diversity and composition of microbial communities in the LRT of Influenza patients and its relationship with clinical variables and disease severity.
多种因素与流感病毒引起的呼吸道疾病的严重程度有关。尽管病毒因素是研究最多的因素之一,但近年来,微生物组和合并感染在严重和致命结果中的作用已得到认可。然而,大多数工作都集中在上呼吸道(URT)的微生物组上,这阻碍了从下呼吸道(LRT)获得的潜在见解,而下呼吸道的见解可能有助于了解微生物组在流感疾病中的作用。在这项工作中,我们使用 16S rRNA 测序对甲型流感患者的 LRT 微生物组进行了特征描述。我们测试了具有不同结局(死亡/康复)和使用抗生素的患者在其微生物群落组成上是否存在差异。我们发现死亡和康复患者之间的微生物组多样性和组成存在重要差异。特别是,我们在死亡或接受抗生素治疗的患者中检测到了机会性病原体如 Granulicatella 的高丰度。此外,我们发现抗生素治疗与微生物群落多样性降低以及甲型流感患者存活概率降低相关。总之,微生物多样性的丧失可能会导致群落失衡,从而潜在地损害免疫反应,增加病毒感染力,促进潜在致病性细菌的生长,这些因素与生化参数的改变一起,可能导致疾病的严重形式。总体而言,本研究首次对流感患者 LRT 中的微生物群落的多样性和组成及其与临床变量和疾病严重程度的关系进行了描述。